PhaseWell Research (“PhaseWell”), a national clinical research site company, announces a new partnership with Bio Behavioral Health (“BBH”), a leading central nervous system (CNS) research site focused in neurologic and psychiatric disorders. The addition of Bio Behavioral Health further strengthens PhaseWell’s growing network and enhances its capabilities in neurologic and psychiatric research – areas of increasing clinical and societal need. Based in Toms River, New Jersey, Bio Behavioral Health brings deep expertise in conducting clinical trials in the community setting, with a strong emphasis on patient-centered care, rigorous data quality, and efficient study execution.
Read the full article: Bio Behavioral Health Joins PhaseWell Research to Expand Access to Neuropsychiatric Clinical Trials //
Source: https://www.businesswire.com/news/home/20260121209920/en/Bio-Behavioral-Health-Joins-PhaseWell-Research-to-Expand-Access-to-Neuropsychiatric-Clinical-Trials